These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17557086)

  • 21. US seeking more transparency from pharma.
    Collier R
    CMAJ; 2016 Apr; 188(7):E115. PubMed ID: 26976964
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug makers skirting law, Sen. Pryor says.
    Wagner L
    Mod Healthc; 1991 Jan; 21(4):14. PubMed ID: 10108753
    [No Abstract]   [Full Text] [Related]  

  • 23. Remuneration for non-interventional studies--results of a survey in the pharmaceutical industry in Germany.
    Ruppert T; Hahn M; Hundt F
    Ger Med Sci; 2012; 10():Doc04. PubMed ID: 22355280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical expenditure compared across countries.
    van Mosseveld C
    Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug importation and safety of drugs obtained from Canada.
    Shepherd M
    Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C drug maker puts profit ahead of patients, US Senate report charges.
    McCarthy M
    BMJ; 2015 Dec; 351():h6573. PubMed ID: 26635239
    [No Abstract]   [Full Text] [Related]  

  • 28. The pricing of pharmaceuticals: an international comparison.
    Dickson M
    Clin Ther; 1992; 14(4):604-10; discussion 603. PubMed ID: 1525794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Federal drug discount program proves tricky for hospitals to navigate.
    Thompson CA
    Am J Health Syst Pharm; 2000 Dec; 57(23):2130, 2134, 2139-40. PubMed ID: 11127690
    [No Abstract]   [Full Text] [Related]  

  • 30. A proposal for financing postmarketing drug safety studies by augmenting FDA user fees.
    Carpenter D
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-469-80. PubMed ID: 16234281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spending on postapproval drug safety.
    Ridley DB; Kramer JM; Tilson HH; Grabowski HG; Schulman KA
    Health Aff (Millwood); 2006; 25(2):429-36. PubMed ID: 16522583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmaceutical industry pricing practices: impact of the Bayer settlement.
    Berkle M
    Health Care Law Mon; 2001 Jul; ():3-11. PubMed ID: 11484634
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmaceutical industry--to whom is it accountable?
    Summers WK; Driscoll J; Orient JM
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183883
    [No Abstract]   [Full Text] [Related]  

  • 35. The prescription Drug User Fee Act of 1992 and the new drug development process.
    Kaitin KI
    Am J Ther; 1997; 4(5-6):167-72. PubMed ID: 10423607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 37. The drug safety system conundrum.
    Tiedt TN
    Food Drug Law J; 2007; 62(3):547-558. PubMed ID: 17915396
    [No Abstract]   [Full Text] [Related]  

  • 38. Higher profile puts them in the crosshairs.
    Calandra R
    Manag Care; 2016 Dec; 25(12):28-29. PubMed ID: 28121556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heartbreak of drug pricing.
    Davidoff F
    Ann Intern Med; 2001 Jun; 134(11):1068-71. PubMed ID: 11388821
    [No Abstract]   [Full Text] [Related]  

  • 40. Will Courts Allow States to Regulate Drug Prices?
    Robertson C
    N Engl J Med; 2018 Sep; 379(11):1000-1002. PubMed ID: 30088965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.